Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical implications and genetical insights of SOX6 expression in acute myeloid leukemia.

Journal of cancer research and clinical oncology - 1 Jul 2023

Li Yan, Jiang Duanfeng, Zhang Qin, Liu Enyi, Shao Haigang

Abstract excerpt

BACKGROUND: Transcription factor SOX6 belongs to Sry-related high-mobility-group box (SOX) family, has been reported to be downregulated and acts as a tumor-suppressor gene in various solid tumors, but in acute myeloid leukemia (AML) is incompletely understood. METHODS: The SOX6 expression was analyzed between AML patients and normal controls from public data and our research cohort. Correlations between SOX6...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bone Marrow
Share to Leukemia, Myeloid, Acute
Share to Leukocyte Count

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to SOXD Transcription Factors

Share to Survival Analysis

Source

Identifiers

PMID: 36117190
DOI: 10.1007/s00432-022-04349-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical implications and genetical insights of SOX6 expression in acute myeloid leukemia.PMID 36117190Read ↗

Clinical implications and genetical insights of SOX6 expression in acute myeloid leukemiaSemantic proximity Read ↗

Prognostic significance of SOX2, SOX3, SOX11, SOX14 and SOX18 gene expression in adult de novo acute myeloid leukemia.Semantic proximity Read ↗

Identification and validation of SRY-box containing gene family member SOX30 methylation as a prognostic and predictive biomarker in myeloid malignanciesSemantic proximity Read ↗

SOX6 blocks the proliferation of BCR-ABL1+ and JAK2V617F+ leukemic cellsSemantic proximity Read ↗

Clinical Correlation of Transcription Factor SOX3 in Cancer: Unveiling Its Role in TumorigenesisSemantic proximity Read ↗

Distinct association of RUNX family expression with genetic alterations and clinical outcome in acute myeloid leukemia.Semantic proximity Read ↗

Systematic Investigation of the Multifaceted Role of SOX11 in CancerSemantic proximity Read ↗

Splicing factor-mediated regulation patterns reveals biological characteristics and aid in predicting prognosis in acute myeloid leukemiaSemantic proximity Read ↗

Sox4 is a key oncogenic target in C/EBPα mutant acute myeloid leukemia.Semantic proximity Read ↗

Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia.Semantic proximity Read ↗

Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafishSemantic proximity Read ↗

Six1 regulates leukemia stem cell maintenance in acute myeloid leukemiaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.